NAUT
Nautilus Biotechnology Inc
NASDAQ: NAUT · HEALTHCARE · BIOTECHNOLOGY
$2.50
-3.47% today
Updated 2026-04-29
Market cap
$317.70M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-0.46
Dividend yield
—
52W range
$1 – $4
Volume
0.3M
Nautilus Biotechnology Inc (NAUT) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-238.30M | $-9.66M | $-14.00M | $-39.24M | $-45.81M | $-51.71M | $-59.15M | $-50.70M |
| Capital expenditures | $0.00 | $926000.00 | $921000.00 | $2.27M | $2.32M | $2.44M | $2.12M | $1.28M |
| Depreciation | — | — | — | — | — | — | — | — |
| Stock-based comp | — | $110000.00 | $369000.00 | $7.93M | $10.38M | $12.14M | $12.70M | $6.84M |
| Free cash flow | $-238.30M | $-10.59M | $-14.92M | $-41.51M | $-48.13M | $-54.15M | $-61.27M | $-51.97M |
| Investing cash flow | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | $52952.00 | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | $149.24M | $-70.98M | — | — | — |